Mint Tower Capital Management B.V. Amgen Inc Call Options Transaction History

Mint Tower Capital Management B.V.

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $137,418 - $174,606	600 Added 7.69%	8,400 $2.21 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $1.03 Million - $1.16 Million	-4,600 Reduced 37.1%	7,800 $1.76 Million
Q2 2022 Aug 05, 2022	SELL	$230.71 - $256.74 $299,923 - $333,762	-1,300 Reduced 9.49%	12,400 $3.02 Million
Q1 2022 Apr 29, 2022	BUY	$219.27 - $242.57 $3 Million - $3.32 Million	13,700 New	13,700 $3.31 Million
Q2 2020 Aug 06, 2020	SELL	$197.81 - $242.74 $1.98 Million - $2.43 Million	-10,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $1.74 Million - $2.09 Million	10,000 New	10,000 $1.94 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $18,087 - $20,388	-100 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $17,840 - $20,825	100 New	100 $19,000
Q3 2018 Nov 06, 2018	SELL	$185.29 - $208.89 $3.71 Million - $4.18 Million	-20,000 Closed	0 $0
Q1 2018 May 09, 2018	BUY	$169.43 - $198.0 $3.39 Million - $3.96 Million	20,000 New	20,000 $3.41 Million

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Mint Tower Capital Management B.V., based on Form 13F filings with the SEC.

Stay updated on Mint Tower Capital Management B.V. with notifications on news.